Flower One Holdings Inc. (OTCPK: FLOO.F)
Health Care · Pharmaceuticals · CA
$—
— today · — 1Y
Flower One Holdings Inc. (OTCPK: FLOO.F) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $473.00.
trading between 0.00 and 0.00.
Tweenvest scores Flower One Holdings Inc. across four factors: quality 23/100, value 45/100. Its strongest factor is value.
FLOO.F price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $473.00
- Revenue (TTM)
- $43.07M
- P/E
- —
- EPS
- -0.05
- Dividend yield
- —
- Beta (5Y)
- -24.74
- 52-week high
- $0.00
- 52-week low
- $0.00
- Avg volume (3M)
- —
- Shares outstanding
- 473.10M
- Employees
- —
- Next earnings
- —
About Flower One Holdings Inc.
Flower One Holdings Inc. engages in the cultivation and production of medical and recreational cannabis. It owns and operates 400,000 square foot greenhouse for cannabis cultivation and 55,000 square foot cannabis production facility in Nevada; and 25,000 square-feet indoor cultivation and a commercial kitchen in Las Vegas. The company cultivates, processes, produces, packages, and wholesales dry flower, pre-rolls, cannabis oils, distillates, concentrates, edibles, beverages, topicals, and infused products. It provides cannabis products under the NLVO brand name. The company sells its products directly to dispensaries, as well as engages in the contract cultivation, production, and packaging for consumer cannabis brands. Flower One Holdings Inc. is based in Vancouver, Canada.
- ISIN
- CA34348Q1028
- Listed since
- Jul 19, 2007
- Exchange
- Pink Sheets LLC
- Currency
- USD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.10T | $1,226.58 | -0.57% |
| Johnson & JohnsonNYSE: JNJ | $658.24B | $271.58 | -0.57% |
| Merck & Co., Inc.NYSE: MRK | $385.99B | $153.68 | -1.77% |
| Roche Holding AGSWX: ROP | $371.62B | CHF369.70 | -1.10% |
| Novartis AGSWX: NOVN | $303.81B | CHF128.34 | +1.25% |
| AstraZeneca PLCLSE: AZN | $263.84B | £122.92 | -1.47% |
| Novo Nordisk A/SCPSE: NOVO B | $212.51B | Dkr307.80 | +2.86% |
| Pfizer Inc.NYSE: PFE | $162.84B | $28.35 | -0.77% |
Figures last refreshed Aug 18, 2026.